Braude S, Royston D, Coe C, Barnes P J
Lancet. 1984 Aug 18;2(8399):372-4. doi: 10.1016/s0140-6736(84)90542-7.
The effect of specific H1 and H2 receptor antagonists on bronchial reactivity and increase in lung epithelial permeability in response to inhaled histamine was measured in 5 non-smoking men (age range 24-36 years). Inhaled histamine produced a short-lived but consistent increase in permeability to 99Tc-diethylenetriamine penta-acetate. An H1-receptor antagonist, terfenadine (60 mg), protected against the bronchoconstrictor effect but had no significant influence on the increase in permeability. The H2-receptor antagonist ranitidine (150 mg) significantly reduced the permeability response without having an effect on bronchial reactivity. These results demonstrate that the bronchoconstrictor effect of histamine is mediated by H1 receptors and permeability increase is mediated by H2 receptors. H2-receptor mediated increase in lung epithelial permeability may be important clinically.
在5名不吸烟男性(年龄范围24 - 36岁)中,测量了特定H1和H2受体拮抗剂对支气管反应性以及吸入组胺后肺上皮通透性增加的影响。吸入组胺使99Tc - 二乙三胺五乙酸的通透性出现短暂但持续的增加。H1受体拮抗剂特非那定(60毫克)可预防支气管收缩效应,但对通透性增加无显著影响。H2受体拮抗剂雷尼替丁(150毫克)显著降低了通透性反应,而对支气管反应性无影响。这些结果表明,组胺的支气管收缩效应由H1受体介导,通透性增加由H2受体介导。H2受体介导的肺上皮通透性增加在临床上可能很重要。